Skip to main content
. 2023 Jul 8;9(7):e18128. doi: 10.1016/j.heliyon.2023.e18128

Fig. 5.

Fig. 5

The clinical significance of GPD1 in different populations of breast cancers. (A) The overall survival at different expression levels of GPD1. (B) The Kaplan-Meier survival analysis between the GPD1 expression level and menopause status, including pre-menopause, peri-menopause, and post-menopause. (C) GPD1 expression levels in different breast cancer races.